Skip to main content
. 2022 Aug 21;14(16):4036. doi: 10.3390/cancers14164036
HCC Hepatocellular carcinoma
ICIs Immune checkpoint inhibitors
TME Tumor microenvironment
CTLA-4 Cytotoxic-T-lymphocyte-associated protein 4
PD-1 Programmed cell death protein 1
PD-L1 Programmed cell death ligand 1
EV Extracellular vesicle
TEXs Tumor-cell-derived exosomes
NK Nature killer
DCs Dendritic cells
HMGB1 High mobility group box1
DEXs DC-derived exosomes
SD Spleen deficiency
DC-TEX TEX-pulsed DCs
DEX-AFP AFP-expressing DCs
AD5 Type V adenovirus
CAR-T Chimeric antigen receptor T
TAMs Tumor-associated macrophages
MSCs Mesenchymal stem cells
BMSCs Bone MSCs
ELISA Enzyme-linked immunosorbent assay
CTCs Circulating tumor cells